Impact of less invasive axillary staging procedures after neoadjuvant systemic therapy on adjuvant systemic therapy indications in HER2-positive and triple-negative breast cancer
{{output}}
Objective: To determine how often the indication for adjuvant systemic therapy (AST) in HER2+ and TN breast cancer is based solely on residual axillary disease (ypT0N+) and to estimate the theoretical frequency with which less in... ...
